[Endometrial study made during the continuous administration of microdoses of 30 micrograms of d-norgestrel].
Alvarado
R
R
Lopez-escobar
G
G
Willomitzer
H
H
Castillo
J D
JD
D001695:Biology; D003267:Contraception; D003270:Contraceptive Agents; D003271:Contraceptive Agents, Female; D003276:Contraceptives, Oral; D004717:Endometrium; D005193:Family Planning Services; D005835:Genitalia; D005836:Genitalia, Female; D016912:Levonorgestrel; D010827:Physiology; D045167:Progesterone Congeners; D012106:Research; D014566:Urogenital System; D014599:Uterus
D003270:Contraceptive Agents; D003271:Contraceptive Agents, Female; D003276:Contraceptives, Oral; D045167:Progesterone Congeners; D016912:Levonorgestrel
Biology; Clinical Research; Contraception; Contraceptive Agents, Female--administraction and dosage; Contraceptive Agents, Female--side effects; Contraceptive Agents, Progestin--administraction and dosage; Contraceptive Agents, Progestin--side effects; Contraceptive Agents--administraction and dosage; Contraceptive Agents--side effects; Contraceptive Methods--side effects; Endometrial Effects; Endometrium; Family Planning; Genitalia; Genitalia, Female; Levonorgestrel--administraction and dosage; Levonorgestrel--side effects; Oral Contraceptives, Low-dose; Oral Contraceptives--side effects; Physiology; Progestins, Low-dose; Research Methodology; Urogenital System; Uterus